John D. Hainsworth
0000-0002-2848-6546
Publication & Citation Trends
Publications
0 total
Abstract 1209: Tumor informed circulating tumor DNA monitoring for early treatment response and survival outcomes on trastuzumab + pertuzumab
Cited by 0
Semantic Scholar
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2–Altered Advanced Solid Tumors OA
Cited by 34
Semantic Scholar
Abstract CT032: Activity and safety of alectinib for ALK-altered solid tumors from MyPathway
Cited by 4
Semantic Scholar
66O MyPathway: A multiple target, multiple basket study of targeted treatments in tissue-agnostic cohorts of patients (pts) with advanced solid tumors OA
Cited by 1
Semantic Scholar
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Cited by 118
Semantic Scholar
Data-driven multivariate cohort selection and automated CT scan lung volume measurement identifies disease progression in Idiopathic Pulmonary Fibrosis (IPF)
Cited by 1
Semantic Scholar
Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy OA
Cited by 17
Semantic Scholar
Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma OA
Cited by 3
Semantic Scholar
Research Topics
Lung Cancer Research Studies
(158)
Lung Cancer Treatments and Mutations
(138)
Cancer Treatment and Pharmacology
(132)
Neuroendocrine Tumor Research Advances
(100)
Cancer Diagnosis and Treatment
(100)
Affiliations
University of Central Florida
Boston University
Northwestern University
Ontario Institute for Cancer Research
University of Southern California